MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


0026-895X/04/6601-137-143$20.00
Mol Pharmacol 66:137-143, 2004

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gnegy, M. E.
Right arrow Articles by Galli, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gnegy, M. E.
Right arrow Articles by Galli, A.

Intracellular Ca2+ Regulates Amphetamine-Induced Dopamine Efflux and Currents Mediated by the Human Dopamine Transporter

Margaret E. Gnegy, Habibeh Khoshbouei, Kelly A. Berg, Jonathan A. Javitch, William P. Clarke, Minjia Zhang, and Aurelio Galli

Department of Pharmacology, University of Michigan, Ann Arbor, Michigan (M.E.G., M.Z.); Department of Molecular Physiology and Biophysics, Vanderbilt University, Nashville, Tennessee (H.K., A.G.); Department of Pharmacology, University of Texas Health Science Center at San Antonio, San Antonio, Texas (K.A.B., W.P.C.); and Center for Molecular Recognition and Departments of Pharmacology and Psychiatry, College of Physicians and Surgeons, Columbia University, New York, New York (J.A.J.)

Although it is clear that amphetamine-induced dopamine (DA) release mediated by the dopamine transporter (DAT) is integral to the behavioral actions of this psychostimulant, the mechanism of this release is not clear. In this study, we explored the requirement for intracellular Ca2+ in amphetamine-induced DA efflux and currents mediated by the human DAT. The patch-clamp technique in the whole-cell configuration was used on Na+ and DA-preloaded human embryonic kidney 293 cells stably transfected with the human DAT (hDAT cells). Chelation of intracellular Ca2+ by inclusion of 50 µM BAPTA in the whole-cell pipette reduced the voltage-dependent amphetamine-induced hDAT current, with the greatest effect seen at positive voltages. Likewise, 1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid (BAPTA) reduced amphetamine-induced DA efflux as measured by amperometry. Furthermore, preincubation of the cells with 50 µM BAPTA acetoxy methyl ester (AM) or thapsigargin also blocked amphetamine-induced release of preloaded N-methyl-4-[3H]phenylpyridinium from superfused hDAT cells. BAPTA-AM also reduced DA release from striatal synaptosomes. Amphetamine also led to an increase in intracellular Ca2+ that was blocked by prior treatment with 5 µM thapsigargin or 10 µM cocaine. These studies demonstrate that amphetamine-induced DAT-mediated currents and substrate efflux require internal Ca2+ and that amphetamine can stimulate dopamine efflux by regulating cytoplasmic Ca2+ levels through its interaction with DAT.


Received November 7, 2003; accepted April 12, 2004

Address correspondence to: Margaret E. Gnegy, Department of Pharmacology, 2220E MSRB III, University of Michigan Medical School, Ann Arbor, MI 48109-0632. E-mail: pgnegy{at}umich.edu




This article has been cited by other articles:


Home page
Stem CellsHome page
J. A. Rodriguez-Gomez, J.-Q. Lu, I. Velasco, S. Rivera, S. S. Zoghbi, J.-S. Liow, J. L. Musachio, F. T. Chin, H. Toyama, J. Seidel, et al.
Persistent Dopamine Functions of Neurons Derived from Embryonic Stem Cells in a Rodent Model of Parkinson Disease
Stem Cells, April 1, 2007; 25(4): 918 - 928.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
Y. Wei, J. M. Williams, C. Dipace, U. Sung, J. A. Javitch, A. Galli, and C. Saunders
Dopamine Transporter Activity Mediates Amphetamine-Induced Inhibition of Akt through a Ca2+/Calmodulin-Dependent Kinase II-Dependent Mechanism
Mol. Pharmacol., March 1, 2007; 71(3): 835 - 842.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
C. Dipace, U. Sung, F. Binda, R. D. Blakely, and A. Galli
Amphetamine Induces a Calcium/Calmodulin-Dependent Protein Kinase II-Dependent Reduction in Norepinephrine Transporter Surface Expression Linked to Changes in Syntaxin 1A/Transporter Complexes
Mol. Pharmacol., January 1, 2007; 71(1): 230 - 239.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. A. Cervinski, J. D. Foster, and R. A. Vaughan
Psychoactive Substrates Stimulate Dopamine Transporter Phosphorylation and Down-regulation by Cocaine-sensitive and Protein Kinase C-dependent Mechanisms
J. Biol. Chem., December 9, 2005; 280(49): 40442 - 40449.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
B. G. Garcia, Y. Wei, J. A. Moron, R. Z. Lin, J. A. Javitch, and A. Galli
Akt Is Essential for Insulin Modulation of Amphetamine-Induced Human Dopamine Transporter Cell-Surface Redistribution
Mol. Pharmacol., July 1, 2005; 68(1): 102 - 109.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L. A. Johnson, B. Guptaroy, D. Lund, S. Shamban, and M. E. Gnegy
Regulation of Amphetamine-stimulated Dopamine Efflux by Protein Kinase C {beta}
J. Biol. Chem., March 25, 2005; 280(12): 10914 - 10919.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
K. M. Kahlig, F. Binda, H. Khoshbouei, R. D. Blakely, D. G. McMahon, J. A. Javitch, and A. Galli
Amphetamine induces dopamine efflux through a dopamine transporter channel
PNAS, March 1, 2005; 102(9): 3495 - 3500.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2004 by the American Society for Pharmacology and Experimental Therapeutics